Cancer Staging: Definition, Systems, and Purpose in Treatment Planning
Staging describes the anatomical extent of cancer in the body at diagnosis. It is the universal language oncology uses to communicate severity, guide therapy, and estimate prognosis.
Core Components (TNM System)
- T (Tumor): Size and local invasion of primary tumor.
- N (Nodes): Spread to regional lymph nodes.
- M (Metastasis): Spread to distant organs.
Combined into Stages I–IV (higher = more advanced).
Major Staging Systems
- TNM (AJCC/UICC): Standard for most solid tumors.
- Ann Arbor: Lymphomas.
- FIGO: Gynecologic cancers.
- Others: Dukes (colorectal), Rai/Binet (CLL), ISS (myeloma).
Clinical Purpose
- Treatment Selection: Surgery vs. chemo vs. radiation vs. immunotherapy vs. combination.
- Prognosis: Survival rates, recurrence risk by stage.
- Clinical Trial Eligibility: Protocols specify stage criteria.
- Standardized Communication: Oncologists worldwide speak the same staging language.
Restaging
After treatment, restaging (y prefix for post-neoadjuvant, r for recurrence) assesses response and guides next steps.